ArticleCancers2022

Clinical and Molecular Features of KRAS-Mutated Lung Cancer Patients Treated with Immune Checkpoint Inhibitors.

Dan Zhao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.